Selectivity of cyclo-oxygenase inhibitors in human pulmonary epithelial and smooth muscle cells

European Respiratory Journal

Volumn 15, Issue 4, 2000, Pages 751-756

  Range, S P ^a,b   Pang, L ^a   Holland, E ^a   Knox, A J ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

A549 cells; Airway smooth muscle; Asthma cyclo oxygenase; Cyclo oxygenase inhibitor; Prostaglandin E2

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FLURBIPROFEN; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; VALERIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SMOOTH MUSCLE FIBER;

ADULT; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CHICK EMBRYO; CONFIDENCE INTERVALS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; EPITHELIUM; FEMALE; HUMANS; LINEAR MODELS; LUNG; MALE; MIDDLE AGED; MUSCLE, SMOOTH; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY;

EID: 0034088490     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.15d20.x     Document Type: Article

References (41)

1. 4-induced bronchoconstriction in guinea-pigs. Int Arch Allergy Immunol 1995; 108: 68-73.
2. 2-induced bronchoconstriction is mediated only in part by the thromboxane prostanoid receptor. Eur Respir J 1995; 8: 411-415.
3. 2. Lancet 1995; 345: 436-438.
4. Bianco S, Vaghi A, Pieroni MG, Robuschi M, Refini RM, Sestini P. Protective activity of inhaled non-steroidal anti-inflammatory drugs on bronchial responsiveness to ultrasonically nebulised water. J Allergy Clin Immunol 1992; 90: 833-839.
5. Polosa R, Milazzo VL, Magri S, et al. Activity of inhaled lysine acetylsalicylate (L-ASA) on bradykinin-induced bronchoconstriction in asthmatics: evidence of contribution of prostaglandins. Eur Respir J 1997; 10: 866-871.
6. 2 on excitory neuro-effector transmission in the human bronchus. Prostaglandins 1990; 39: 639-655.
7. Peters SP, Schulman ES, Schleimer RP, Macglashan DW, Newball HH, Lichtenstein LM. Dispersed human lung mast cells. Pharmacologic aspects and comparison with human lung fragments. Am Rev Respir Dis 1982; 126: 1034-1039.
8. 2 on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma. Thorax 1991; 46: 633-637.
9. 2 on exercise-induced bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 1994; 149: 1138-1141.
10. Mattoli S, Foresi A, Corbo GM, Valente S, Ciappi G. The effect of indomethacin on the refractory period occurring after the inhalation of ultrasonically nebulised distilled water. J Allergy Clin Immunol 1987; 79: 678-683.
11. O'Byrne PM, Jones GL. The effect of indomethacin on exercise-induced bronchoconstriction and refractoriness after exercise. Am Rev Respir Dis 1986; 134: 69-72.
12. 2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1996; 153: 572-575.
13. Szczeklik A, Mastalerz L, Nizankowska E, Cmiel A. Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin induced asthma. Am J Respir Crit Care Med 1996; 153: 567-571.
14. Pang L, Holland H, Knox AJ. Role of COX 2 induction in interleukin-1β induced attenuation of cultured human airway smooth muscle cell cAMP generation in response to isoprenaline. Br J Pharmacol 1998; 125: 1320-1328.
15. Pang L, Holland H, Knox AJ. Impaired cAMP production in human airway smooth muscle cells by bradykinin: role of cyclooxygenase products. Am J Physiol (Lung Cell Mol Physiol) 1998; 275: L322-L329.
16. Pang L, Knox AJ. Bradykinin stimulated IL-8 production in cultured human airway smooth muscle cells: role of cyclooxygenase products. J Immunol 1998; 161: 2509-2515.
17. 2 and express COX 2. J Clin Invest 1995; 95: 1861-1868.
18. Levistre R, Lemnaouar M, Rybkine T, Bereziat G, Masliah J. Increase of bradykinin-stimulated arachidonic acid release in a delta F508 cystic fibrosis epithelial cell line. Biochim Biophys Acta 1993; 1181: 233-239.
19. Konstan MW, Byard PJ, Hoppel CL, Davis PB. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 1995; 332: 848-854.
20. Simmons DL, Xie W, Chipman JG, Evett GE. Multiple cyclooxygenases: cloning of a mitogen-inducible form. In: Bailey JM, ed. Prostaglandins, Leukotrienes, Lipoxins and PAR New York, NY, USA, Plenum, 1991; pp. 67-78.
21. Mitchell JA, Belvisi MG, Akarasereenont P, et al. Induction of cyclo-oxygenase-2 in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol 1994; 113: 1008-1014.
22. Pang LH, Knox AT. Effect of interleukin-1β tumour necrosis factor-a and interferon-γ on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells. Br J Pharmacol 1997; 121: 579-587.
23. 2 release by bradykinin in human airway smooth muscle cells: involvement of cyclooxygenase-2 induction. Am J Physiol (Lung Cell Mol Biol) 1997; 273: L1132-L1140.
24. Sousa AR, Pfister R, Christie PE, et al. Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax 1997; 52: 940-945.
25. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1994; 90: 11693-11697.
26. Belvisi MG, Saunders MA, Haddad E-B, et al. Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type. Br J Pharmacol 1997; 120: 910-916.
27. 2 in human bronchial smooth muscle cells. Am J Respir Crit Care Med 1997; 155: 864-868.
28. Asano K, Lilly CM, Drazen DM. Prostaglandin G/H synthase-2 is the constitutive and dominant isoform in cultured lung epithelial cells. Am J Physiol (Lung Cell Mol Physiol) 1996; 271: L126-L131.
29. Alpert SE, Walenga RW, Jaspers I, Qu Q, Chen LC. Ozone inactivates cyclooxygenase in human tracheal epithelial cells without altering PGHS-2 mRNA or protein. Am J Physiol (Lung Cell Mol Physiol) 1997; 272: L879-L887.
30. Hall IP, Widdops S, Townsend P, Daykin K. Control of cyclic AMP levels in primary culture of human tracheal smooth muscle cells. Br J Pharmacol 1992; 107:422-428.
31. 2 by bovine cultured airway smooth muscle cells and its inhibition by cyclo-oxygenase inhibitors. Br J Pharmacol 1994; 111: 983-988.
32. Murakami M, Bingham CO III, Matsumoto R, Austen KF, Arm JP. IgE-dependent activation of cytokine-primed mouse cultured mast cells induces a delayed phase of prostaglandin D2 generation via prostaglandin endoperoxide synthase-2. J Immunol 1995; 155: 4445-4453.
33. Chulada P, Langenbach R. Differential inhibition of Murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid. J Pharmacol Exp Therapeutics 1997; 280: 606-613.
34. Meade EA, Smith WL, Dewitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isoenzymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993; 268: 6610-6614.
35. Curnock AP, Robson PA, Yea CM, et al. Potencies of leflunomide and HR325 as inhibitors of prostaglandin endoperoxide H synthase-1 and -2: comparison with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Therapeutics 1997; 282: 339-347.
36. Tavares IA, Bishai PM, Bennett A. Activity of nimesulide on constitutive and inducible cyclooxygenases. Arzneimittel-Forschung 1995; 45: 1093-1095.
37. Mattoli S, Mattoso VL, Solopertro M, Allegra L, Fasoli A. Cellular and biochemical characteristics of broncho-alveolar lavage fluid in symptomatic non-allergic asthma. J Allergy Clin Immunol 1991; 87: 794-802.
38. Broide DH, Lotz M, Cuomo AG, Coburn DA, Federman EC, Wasserman SI. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992; 89: 958-967.
39. Bianco S, Robuschi M, Petrigni G, et al. Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin. Drugs 1993; 46: Suppl. 1, 115-120.
40. Crimi N, Polosa R, Magri S, et al. Inhaled lysine acetylsalicylate (L-ASA) attenuates the bronchoconstrictor response to adenosine 5′monophosphate (AMP) in asthmatic subjects. Eur Respir J 1995; 8: 905-912.
41. O'Connor BJ, Barnes PJ, Chung KF. Inhibition of sodium metabisulphite-induced bronchoconstriction by frusemide in asthma: role of cyclooxygenase products. Thorax. 1994; 49: 307-311.